Davidson Investment Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $16M | Sell |
277,201
-15,902
| -5% | -$913K | 0.65% | 59 |
|
|
2026
Q1 | $17.8M | Sell |
293,103
-6,411
| -2% | -$374K | 0.77% | 51 |
|
|
2025
Q4 | $16.2M | Sell |
299,514
-3,839
| -1% | -$185K | 0.67% | 61 |
|
|
2025
Q3 | $13.7M | Buy |
303,353
+12,492
| +4% | +$583K | 0.58% | 69 |
|
|
2025
Q2 | $13.5M | Sell |
290,861
-9,505
| -3% | -$467K | 0.61% | 69 |
|
|
2025
Q1 | $18.3M | Buy |
300,366
+9,045
| +3% | +$527K | 0.9% | 42 |
|
|
2024
Q4 | $16.5M | Buy |
291,321
+3,784
| +1% | +$211K | 0.8% | 52 |
|
|
2024
Q3 | $14.9M | Buy |
287,537
+12,995
| +5% | +$610K | 0.72% | 64 |
|
|
2024
Q2 | $11.4M | Buy |
274,542
+4,631
| +2% | +$207K | 0.59% | 74 |
|
|
2024
Q1 | $14.6M | Buy |
269,911
+18,401
| +7% | +$937K | 0.76% | 61 |
|
|
2023
Q4 | $12.9M | Sell |
251,510
-6,435
| -2% | -$338K | 0.74% | 63 |
|
|
2023
Q3 | $15M | Buy |
257,945
+5,965
| +2% | +$365K | 0.95% | 49 |
|
|
2023
Q2 | $16.1M | Buy |
251,980
+41,270
| +20% | +$2.77M | 1.02% | 41 |
|
|
2023
Q1 | $14.6M | Buy |
210,710
+20,614
| +11% | +$1.45M | 0.96% | 47 |
|
|
2022
Q4 | $13.7M | Buy |
190,096
+3,681
| +2% | +$278K | 1.06% | 42 |
|
|
2022
Q3 | $13.3M | Buy |
186,415
+7,568
| +4% | +$549K | 1.11% | 35 |
|
|
2022
Q2 | $13.8M | Buy |
178,847
+1,831
| +1% | +$139K | 1.17% | 34 |
|
|
2022
Q1 | $12.9M | Buy |
177,016
+3,125
| +2% | +$210K | 0.94% | 54 |
|
|
2021
Q4 | $10.8M | Sell |
173,891
-3,370
| -2% | -$198K | 0.77% | 56 |
|
|
2021
Q3 | $10.5M | Buy |
177,261
+6,299
| +4% | +$415K | 0.82% | 59 |
|
|
2021
Q2 | $11.4M | Sell |
170,962
-2,101
| -1% | -$137K | 0.91% | 51 |
|
|
2021
Q1 | $10.9M | Buy |
173,063
+5,876
| +4% | +$366K | 0.93% | 55 |
|
|
2020
Q4 | $10.4M | Sell |
167,187
-1,805
| -1% | -$111K | 0.96% | 55 |
|
|
2020
Q3 | $10.2M | Sell |
168,992
-347
| -0.2% | -$20.9K | 1.08% | 35 |
|
|
2020
Q2 | $9.96M | Buy |
169,339
+39,910
| +31% | +$2.39M | 1.1% | 29 |
|
|
2020
Q1 | $7.21M | Sell |
129,429
-5,308
| -4% | -$324K | 0.93% | 49 |
|
|
2019
Q4 | $8.65M | Buy |
+134,737
| New | +$7.72M | 0.84% | 53 |
|
|
2017
Q3 | – | Sell |
-2,240
| Closed | -$124K | – | 114 |
|
|
2017
Q2 | $124K | Hold |
2,240
| – | – | 0.02% | 106 |
|
|
2017
Q1 | $121K | Buy |
2,240
+390
| +21% | +$21.4K | 0.02% | 112 |
|
|
2016
Q4 | $107K | Buy |
1,850
+150
| +9% | +$8.2K | 0.02% | 118 |
|
|
2016
Q3 | $91K | Buy |
1,700
+400
| +31% | +$25.7K | 0.01% | 118 |
|
|
2016
Q2 | $95K | Hold |
1,300
| – | – | 0.02% | 118 |
|
|
2016
Q1 | $83K | Buy |
1,300
+1,000
| +333% | +$63.1K | 0.01% | 152 |
|
|
2015
Q4 | $20K | Hold |
300
| – | – | ﹤0.01% | 186 |
|
|
2015
Q3 | $17K | Buy |
+300
| New | +$19K | ﹤0.01% | 180 |
|
|
2015
Q2 | – | Sell |
-1,000
| Closed | -$64K | – | 203 |
|
|
2015
Q1 | $64K | Sell |
1,000
-500
| -33% | -$31.3K | 0.01% | 152 |
|
|
2014
Q4 | $88K | Sell |
1,500
-2,000
| -57% | -$113K | 0.01% | 139 |
|
|
2014
Q3 | $168K | Buy |
3,500
+2,000
| +133% | +$99.9K | 0.01% | 147 |
|
|
2014
Q2 | $72K | Hold |
1,500
| – | – | 0.01% | 148 |
|
|
2014
Q1 | $77K | Hold |
1,500
| – | – | 0.01% | 140 |
|
|
2013
Q4 | $79K | Sell |
1,500
-500
| -25% | -$25.5K | 0.01% | 134 |
|
|
2013
Q3 | $92K | Hold |
2,000
| – | – | 0.01% | 126 |
|
|
2013
Q2 | $89K | Buy |
+2,000
| New | +$86.8K | 0.01% | 128 |
|
Other funds holding BMY
LMFP
AIM
FWIA
DLA
Davidson Investment Advisors's BMY Position: Q2 2026 in Review
Davidson Investment Advisors reduced its Bristol-Myers Squibb (BMY) stake by 5.4% in Q2 2026, selling an estimated $913K and leaving 277,201 shares worth $16M. The position accounts for 0.65% of the portfolio, ranked #59.
Davidson Investment Advisors first reported a position in BMY in Q2 2013 and has held it in 43 quarters since. The position peaked at $18.3M in Q1 2025. 796 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Davidson Investment Advisors held 277,201 shares of Bristol-Myers Squibb worth $16M as of Q2 2026.
- Davidson Investment Advisors sold 15,902 Bristol-Myers Squibb shares in Q2 2026, an estimated $913K.
- Bristol-Myers Squibb made up 0.65% of Davidson Investment Advisors's portfolio in Q2 2026, its #59 holding.
- Davidson Investment Advisors first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 43 quarters since.
- Davidson Investment Advisors's Bristol-Myers Squibb position peaked at $18.3M in Q1 2025.
- 796 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Davidson Investment Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.